Syndax Pharmaceuticals, Inc.
SNDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60,715 | -$71,847 | -$84,846 | -$94,169 |
| Dep. & Amort. | -$164 | $55 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,082 | $13,787 | $10,380 | $12,297 |
| Change in WC | -$23,379 | -$26,751 | -$17,430 | $27,186 |
| Other Non-Cash | $1,641 | -$3,039 | -$3,266 | -$2,702 |
| Operating Cash Flow | -$70,535 | -$87,795 | -$95,162 | -$57,388 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$131 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$30,440 | -$91,713 | -$10,538 | -$376,314 |
| Inv. Sales/Matur. | $103,000 | $133,600 | $104,680 | $107,341 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $72,429 | $41,887 | $94,142 | -$268,973 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $6,278 | $551 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $930 | $347,425 |
| Financing Cash Flow | $6,278 | $551 | $930 | $347,425 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,172 | -$45,357 | -$90 | $21,064 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108,853 | $154,210 | $154,300 | $133,236 |
| End Cash | $117,025 | $108,853 | $154,210 | $154,300 |
| Free Cash Flow | -$70,666 | -$87,795 | -$95,162 | -$57,388 |